David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.33% |
| 2 | Technology | 14.87% |
| 3 | Consumer Discretionary | 9.92% |
| 4 | Healthcare | 7.34% |
| 5 | Financials | 7.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Mobix Labs
MOBX
$19.4M
| $2.79M | ﹤0.01% |
+28,242
| New | +$2.74M |
|
|
HGEN
2552
DELISTED
HUMANIGEN, INC.
HGEN
| $2.78M | ﹤0.01% |
469,554
+171,856
| +58% | +$2.41M |
|
2553
CALL
CarMax
KMX
$8.89B
| $2.78M | ﹤0.01% |
21,700
+17,400
| +405% | +$2.32M |
|
2554
Adecoagro
AGRO
$1.54B
| $2.77M | ﹤0.01% |
307,223
-418,057
| -58% | -$3.93M |
|
2555
PUT
Consolidated Edison
ED
$39.5B
| $2.77M | ﹤0.01% |
38,200
-2,000
| -5% | -$149K |
|
|
ACB
2556
CALL
Aurora Cannabis
ACB
$254M
| $2.77M | ﹤0.01% |
40,010
| – | – |
|
2557
First Bancorp
FBP
$4.23B
| $2.76M | ﹤0.01% |
210,198
-392,506
| -65% | -$4.83M |
|
|
OEPW
2558
DELISTED
One Equity Partners Open Water I Corp. Class A Common Stock
OEPW
| $2.76M | ﹤0.01% |
283,939
+183,939
| +184% | +$1.78M |
|
|
PEAR
2559
DELISTED
Pear Therapeutics, Inc. Class A Common Stock
PEAR
| $2.76M | ﹤0.01% |
277,432
| – | – |
|
2560
CALL
Viasat
VSAT
$10B
| $2.75M | ﹤0.01% |
50,000
| – | – |
|
|
FATH
2561
DELISTED
Fathom Digital Manufacturing Corporation
FATH
| $2.75M | ﹤0.01% |
13,968
| – | – |
|
|
RCM
2562
DELISTED
R1 RCM Inc. Common Stock
RCM
| $2.75M | ﹤0.01% |
+124,854
| New | +$2.58M |
|
2563
WesBanco
WSBC
$3.88B
| $2.75M | ﹤0.01% |
+80,615
| New | +$2.67M |
|
2564
PUT
StoneCo
STNE
$2.2B
| $2.75M | ﹤0.01% |
79,100
+6,100
| +8% | +$317K |
|
|
JOYY
2565
PUT
JOYY Inc
JOYY
$3.66B
| $2.74M | ﹤0.01% |
50,000
| – | – |
|
2566
PUT
Crocs
CROX
$5.83B
| $2.74M | ﹤0.01% |
+19,100
| New | +$2.62M |
|
2567
Hackett Group
HCKT
$278M
| $2.74M | ﹤0.01% |
139,552
-67,030
| -32% | -$1.26M |
|
|
SCAQ
2568
DELISTED
Stratim Cloud Acquisition Corp. Class A Common Stock
SCAQ
| $2.73M | ﹤0.01% |
279,851
+3,066
| +1% | +$29.7K |
|
2569
PUT
GSK
GSK
$101B
| $2.73M | ﹤0.01% |
57,200
-24,000
| -30% | -$1.21M |
|
2570
Stryker
SYK
$124B
| $2.73M | ﹤0.01% |
10,351
+1,560
| +18% | +$417K |
|
2571
PUT
Teradyne
TER
$58.2B
| $2.73M | ﹤0.01% |
25,000
| – | – |
|
2572
CALL
Cboe Global Markets
CBOE
$32.8B
| $2.73M | ﹤0.01% |
22,000
| – | – |
|
2573
PUT
Baker Hughes
BKR
$61.7B
| $2.72M | ﹤0.01% |
110,000
+90,000
| +450% | +$2M |
|
2574
CALL
Logitech
LOGI
$14B
| $2.71M | ﹤0.01% |
30,800
+10,000
| +48% | +$1.08M |
|
2575
Ventas
VTR
$47.6B
| $2.71M | ﹤0.01% |
49,152
-279,409
| -85% | -$16M |
|
Similar funds
David Shaw's Q3 2021 Portfolio in Review
As of Q3 2021, David Shaw held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
David Shaw withdrew a net $13.7B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, up from 35% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Sea Limited worth $206M.
- David Shaw's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- David Shaw added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- David Shaw's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- David Shaw fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- David Shaw's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- David Shaw opened 915 new positions and closed 695 in Q3 2021.
- David Shaw's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.